We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Phadia Introduces Recombinant Control Antibodies into Autoimmune Tests

By Labmedica staff writers
Posted on 24 Jul 2008
Phadia (Freiberg, Germany) has introduced recombinant antibodies into an autoimmune screening platform. More...
AbD Serotec, MorphoSys' (Munich, Germany) division for diagnostic and research antibodies, has a license agreement with Phadia to continuously supply Phadia with the recombinant antibody material.

Serotec generated a series of recombinant antibodies in the immunoglobulin (Ig)A, IgM, and IgG1 formats, which Phadia will implement in its autoimmune tests Varelisa, a classical ELISA microtiter platform, and EliA, a fully automated system for the measurement of autoantibodies EliA. The set of recombinant HuCAL-derived antibodies provided by AbD Serotec act as recombinant control antibodies and replace human serum to standardize autoimmune assays.

Autoimmune diseases include juvenile diabetes, various forms of rheumatism, hepatitis, thyroiditis, and a variety of skin diseases. An early diagnosis can improve treatment options and improve quality of life for patients significantly. However, since the early symptoms, especially of systemic autoimmune diseases such as rheumatoid disorders, can be very diffuse, several years can pass from the onset of the disease until a correct diagnosis is made. New easy-to-use and cost-effective diagnostic methods would shorten the time-to-diagnosis and subsequent treatment.

[The] news marks the first market entry of a clinical diagnostic kit comprising a HuCAL antibody, commented Dr. Simon Moroney, CEO of MorphoSys. This development is a significant step forwards for recombinant antibody technology in the diagnostics field, and a major operational milestone for our antibody (Ab)D unit.

Phadia develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases. The center in Freiberg develops and supports diagnostic tests for autoimmune diseases.

MorphoSys is a biotechnology company focused on the generation of fully human antibodies as a means to discover and develop innovative antibody-based drugs against life-threatening diseases. MorphoSys' goal is to establish HuCAL as the technology of choice for antibody generation in diagnostics, therapeutic applications, and research.


Related Links:
Phadia
MorphoSys

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.